Archiwum hase³
mitogen activated protein kinases {MAP} | Antibody-dependent cellular cytotoxicity {ADCC} | Chronic allograft injury {CAI} | Cell-mediated lympholysis {CML} | Chronic rejection episode {CRE} | Induced regulatory T cells {iTregs} | Killer cell immunoglobulin-like receptor {KIR} | Pattern recognition receptor {PRR} | T helper {Th} | T cytotoxic {Tc} | cluster of differentiation {CD} | cytotoxic T-lymphocyte antigen 4 {CTLA-4} | immunologically competent cells | proinflammatory cytokin | anti-inflammatory cytokine | immunomodulatory factor | Primary pulmonary hipertension {PPH} | Lymphocyte trafficking control | lymphocyte trafficking | Chemotactic migration | costimulatory molecule expression | Creatine phosphokinase {CPK} | nonobese diabetic mouse {NOD} | macrophage deactivating factors | Endothelial NOS {eNOS} | nuclear factor κB {NFxB} | leukocyte trafficking | compensatory anti-inflammatory response syndrom {CARS} | myelin sheath | encephalitogenic T cells | oligodendrocyte precursor cells {OPCs} | cutaneous anaphylaxis | delayed-type hypersensitivity {DTH} | DDS-induced colitis | dysembryoplastic neuroepithelial tumor {DNET}{DNT} | primitive neuroepithelial tumors | cerebellar granule cells {CGC} | pigment epithelium derived factor {PEDF} | retina pigment epithelium {RPE} | middle cerebral artery occlusion | nigrostriatal neurons | permanent middle cerebral artery occlusion {pMCAO} | stress-activated protein kinase {SAPK} | c-Jun N-terminal kinases {JNK} | fetal alcohol syndrome {FAS} | multiple organ dysfunction syndrome {MODS} | inducible nitric oxide synthase {iNOS} | superior cervical ganglion {SCG} | native peptyde | contact sensitivity {CS} reaction | T suppressor {Ts} cells | Toll-like receptor {TLR} ligands | delayed type hypersensitivity {DTH} | Langerhans cells {LC} | pathogen associated molecular patterns {PAMPs} | glial cell-line derived neurotrophic factor {GDNF} | ciliary neurotrophic factor {CTNF} | spontaneously hypertensive rats {SHR} | neglect induced heath {NID} | Bcl-2 antagonist killer 1 {Bak} | Bcl-2-associated protein X {Bax} | B-cell leukemia/ lymphoma-2 {Bcl-2} | B-cell lymphoma-extra large {Bcl-xL} | BH3 interacting domain death antagonist {Bid} | Bcl-2 interacting mediator of cell heath {Bim} | Bcl-2-related ovarian killer {Bok} | cytotoxic lymphocyte {CTL } | Granzyme A {GZMA} | c-Jun N-terminal kinase {JNK} | signal transduced and activator of transcription 5 {STAT-5} | TNFR associated death domain-containing protein {TRADD} | TNF-related apoptosis inducing ligand-receptor {TRAIL} | p53 upregulated modulator of apoptosis {PUMA} | Gastric emptying scintigraphy | Likert scale | test-retest reliability | gastric accommodation | gastric antrum | functional dyspepsia | transrectal ultrasound {TRUS} | alexithymia | The Coping Inventory for Stressful Situations {CISS} | anorectal angle | pelvic floor dysfunction | lactulose breath test | disordered N-terminal domain | Photoaffinity labelling | Rhodopsin-like receptors | synaptic bud | rectoanal inhibitory reflex {RAIR} | neuropsychiatric systemic lupus erythematosus {NPSLE} | postprandial fullness | acute gastric dilatation | food regurgitation | diffuse oesophageal spasm | non cardiac chest pain {NCCP} | transient lower oesophageal sphincter relaxations {TLESRs} | cricopharyngeal muscle | intrabolus pressure | retrosternal pain | esophagogastric junction {EGJ} | gastric fluoroscopic examination | high residue diet | anal verge | internal anal sphincter | Colonic transit time | ideal body weight {IBW} | stool softeners | Rectal compliance | Infantile hypertrophic pyloric stenosis {IHPS} | binge eating dsorder {BED} | nutritional rehabilitation | Laparoscopic Nissen fundoplication | Congenital central hypoventilation syndrome {CCHS} | Iron-deficiency anaemia | iron-refractory iron deficiency anemia {IRIDA} | Thymus- and activation- regulated chemokine {TARC} | dementia with Lewy bodies {DLB} | digital rectal examination {DRE} | endophenotype | quantification | radiopaque marker | Monocyte-derived chemokine {MDC} | bronchial hyperreactivity | activity-dependent neurotrophic factor, {ADNF} | cerebral ischemia. niedokrwienie (ischemia) mózgu | Ischemia-induced changes | endogenous neuroprotective substances endogennych substancji neuroprotekcyjnych | endogenous neuroprotective substances | pituitary adenylate cyclase-activating polypeptide (PACAP) | pleiotropic biological activity | intracellular pathways | functional and manometric evaluation | half emptying time {T1/ 2} | keyhole limpet hemocyanin {KLH} | lymph node cells {LNC} | obstructive defecation | Paget-Schrötter syndrome | protease nexin-1/ glia-derived nexin {PN-1/ GDN} | FLICE inhibitory protein {cFLIP} | Chronic Idiopathic Constipation {CIC} | Synoptophore | Interpupillary distance {IPD) | Pupillary Distance {PD} | dermatitis herpetiformis {DH} | autoimmune blistering subepidermal dermatosis | abnormal retinal correspondence | orthoptic exercise | fusional vergence | spinocerebellar ataxia type 2 {SCA2} | amblyopic eye | after-image | vestibulo-ocular reflex {VOR} | optokinetic reflex {OKR} | excitatory burst neurons {EBN} | paramedian pontine reticular formation {PPRF} | inhibitory burst neurons {IBN} | wall-eyed bilateral internuclear ophthalmoplegia {WEBINO} | interstitial nucleus of Cajal {INC} | gaze-evoked nystagmus | nucleus raphe interpositus {RIP} | medial superior temporal visual area {MST} | frontal eye field {FEF} | dorsolateral pontine nucleus {DLPN} | epidermal transglutaminase | gluten-sensitive enteropathy | elbow crutches | gender identity disorder {GID} | contraction stress test {CST} | adjunctive treatment | aged | discharge summary | female | lipid profile | lymphocytes {Ly} | recommendations | 24 hour urine | Urine sediments (microsc.) | blood count | magnetic resonance imaging {MRI} | Abdominal diagnostics | Acid-base homeostasis | Admitted to the hospital on: | Analysis of variance | Basocyte | Blood platelets | CBC with WBC differential | Chief of the Ward | Co-morbidities | Continuous infusion 24 h | Culture for aerobic bacteria | Discharged from the hospital | easy digestible food | End of test | registration is obligatory on the visit day | Eosinocyte | Examination description | Final clinical diagnosis | Follow-up examination | Hearing screening card |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
